Showing all 2 results

BetriXa 80

1,150.00৳ Strip
  • BetriXa provides effective prophylaxis against venous thromboembolism (VTE) in hospitalized adults with acute medical illnesses.
  • Betrixaban, a factor Xa inhibitor, selectively blocks factor Xa's active site, reducing thrombin generation without affecting platelet aggregation.
  • Administered orally, BetriXa's recommended dosage involves an initial single dose followed by daily doses, all with food.
  • Careful monitoring for bleeding risks and adherence to precautions during certain medical procedures are crucial for optimal safety and efficacy.

RivaXa 10

250.00৳ Strip
  • RivaXa: Available in 2.5 mg and 10-20 mg doses.
  • Prevents Atherothrombotic Events: Post-Acute Coronary Syndrome (ACS).
  • Reduces Risk of Stroke and Systemic Embolism: Especially in nonvalvular atrial fibrillation.
  • Highly Selective Factor Xa Inhibitor: Efficiently disrupts blood coagulation pathways.
  • Manages DVT and PE: Provides effective treatment and prevention strategies.
  • Careful Dosage Guidance: Ensures patient safety and well-being.